Nifty's recovery or just another trap? Analysts split on market's future direction!
Aurobindo Pharma is in focus.
· ET Stocks, Economic Times Markets
Nifty's recent recovery has generated optimism, but a sustained close above key resistance is crucial for further gains. Analysts suggest a cautious approach with potential accumulation of certain stocks during dips. Key stocks for investment include Aurobindo Pharma and TCS, which display strong price momentum and resilience.
The analysis
Against that, the stock is +1.3% on the day at ₹1,681.40, and has returned +6.7% over three months. It sits 3% below its 52-week high. The pharma & healthcare sector has moved -0.9% over the same period, so Aurobindo Pharma is running 7.6 points ahead of its peers.
For Aurobindo Pharma, the question is how much of this is already reflected in the price and how much re-rates the pharma & healthcare peer set alongside it.
Market context
- In focus: Aurobindo Pharma (AUROPHARMA), in Pharma & Healthcare.
- On the day, 2 of 2 are higher: Aurobindo Pharma leads at +1.3% and Tata Consultancy (TCS) trails at +1.0%.
- Over three months: Aurobindo Pharma +6.7% against Pharma & Healthcare -0.9% (7.6 points ahead); Tata Consultancy (TCS) +2.9% against IT -3.1% (6.0 points ahead).
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Aurobindo PharmaAUROPHARMA · Pharma & Healthcare | ₹1,681.40 | +1.3% | +0.6% | +6.7% | -3.0% | 1.2× | — |
| Tata Consultancy (TCS)TCS · IT | ₹2,502.60 | +1.0% | +22.0% | +2.9% | -24.7% | 0.5× | — |
Pharma & Healthcare
1M -0.6% · 3M -0.9%
Aurobindo Pharma
IT
1M +5.2% · 3M -3.1%
Tata Consultancy (TCS)
Prices as of 30 Oct 2026, 16:11 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
No. 2 on Day 1: How Jio Platforms broke India’s market cap hierarchy on debut itself
Nifty Pharma index hits record high; Sun, Laurus, Zydus, Sai rally up to 6%
Stocks To Watch Today: Dixon Tech, Syrma SGS, Sun Pharma, Wipro, Trent Among Others
TCS, Infosys, HCL Tech: Anthropic revenue soars 14-fold in H1 2026 - Can Indian IT stocks benefit from AI boom?
Jefferies Cautious On IT: TCS Rated Underperform, Infosys Hold After $10 Billion FPI Outflow